ACADIA Pharmaceuticals Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of ACAD for the last quarter is 231.04 M USD, and it's 9.14% higher compared to the previous quarter. The net income of Q4 23 is 45.80 M USD.